Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval

Synbiotics Limited, a Wholly Owned Subsidiary of Ambalal Sarabhai Enterprises Limited manufacturing company producing fermentation based Active Pharmaceutical Ingredients and one of the few Amphotericin B manufacturing facility in the world has successfully received approval from The United States Food and Drug Administration (USFDA) inspection consecutively 6 time for GMP compliance without any regulatory actions.

The inspection was conducted in accordance with the compliance program - Active Pharmaceutical Ingredient (API) Process Inspection in the month April 2025.

Shares of AMBALAL SARABHAI ENTERPRISES LTD. was last trading in BSE at Rs. 32.42 as compared to the previous close of Rs. 32.64. The total number of shares traded during the day was 51219 in over 208 trades.

The stock hit an intraday high of Rs. 33.19 and intraday low of 31.50. The net turnover during the day was Rs. 1668147.00.

Source : Equity Bulls

Keywords

AMBALALSARABHAIENTERPRISES INE432A01017 Pharmaceuticals Synbiotics FermentationBased API AmphotericinB ManufacturingFacility USFDA GMPCompliance